About Us

Cancilico: Pioneering AI in Image-Based Diagnostics

At Cancilico, we are at the forefront of integrating artificial intelligence into image-based diagnostics. Founded by a dynamic team of experts in business informatics, computer science, biology, and medicine, we are dedicated to transforming the way diseases such as hematological cancers are diagnosed and studied. Our mission is to harness the power of AI to revolutionize medical diagnostics, making it more accurate, efficient, and accessible.

Our journey began with a shared vision: to address the critical need for innovation in the diagnosis of blood-related diseases. Recognizing the limitations of traditional methods, we embarked on creating AI-driven solutions that could automate and enhance this vital process. The result is a suite of advanced, user-friendly software tools that are reshaping the landscape of image-based diagnostics and research.

Image bg shape
Image bg shape

At the heart of Cancilico lies a commitment to improving patient outcomes and advancing medical research. Our technology not only speeds up diagnostic processes but also offers unparalleled accuracy, helping to unlock new possibilities in treatment and research. By automating routine tasks, we free up valuable time for medical professionals, allowing them to focus on more complex aspects of patient care.

We are driven by the potential to make a real difference in the lives of patients and the medical community. Through continuous innovation and collaboration, we are setting new standards in healthcare technology and paving the way for a healthier future.

Team

Markus Badstübner (CEO)

Technology transfer enthusiast focusing on bringing research in AI technology from lab to the market

Sebastian Riechert (CAIO)

Computer Scientist with a focus on computer vision, especially supervised and weakly supervised image classification and segmentation 

 

Tim Schmittmann (CTO)

Technology allrounder with expertise in full-stack application development, modern web technologies, big data management, deep learning frameworks, DevOps, agile methodologies, and medical imaging software development

Katja Siegert (Head, Q&RA)

Accomplished Quality & Regulatory Affairs Manager adept in international medical device registration, standards compliance, quality management and quality control

Dr.-Ing. Karsten Wendt (Soft-Tech Consultant)

Experienced Computer Scientist with expertise in machine learning, digital health, and data-driven design along with a strong background in data science and industry 4.0

Dr. med. Jan Moritz Middeke
 (CMO)

Distinguished Senior Physician specializing in internal medicine, hematology, and oncology. Expertise in stem cell transplantation, acute leukemias, and chronic lymphocytic leukemia (CLL) with a profound commitment to advancing treatments in these critical areas of medicine

Dr. med. Jan-Niklas Eckardt 
(CSO)

Clinician-Scientist and Resident in Hematology and Medical Oncology striving to shape the emerging field of digital personalized oncology

Dr. Tanmaya Joshi
(CPO)

Seasoned project management professional with a knack for solving problems, along with a passion for driving scientific innovations and creating solutions from the ground up

Cancilico Board Members

Prof. em. Dr. med. Gerhard Ehninger

A serial entrepreneur, renowned clinician, researcher and former Head of Hematology & Oncology at University Hospital Carl Gustav Carus Dresden

David Rittrich

Architect for data-driven businesses with a strong background in cloud transformation and focus on data engineering

Prof. Dr. med. Jochen Hampe

Director of Medical Clinic I at University Hospital Carl Gustav Carus and Professor for Internal Medicine and Gastroenterology at Dresden University of Technology

Cancilico Advisory Board Members

Dr. med. Stefani Parmentier

Distinguished Hematologist and leading Physician at the Claraspital Basel Tumor Center

Prof. Jakob N. Kather

Professor for Clinical Artificial Intelligence at Dresden University of Technology focussing on deep learning for immunotherapy biomarkers in cancer

Prof. Dr. med. Martin Bornhäuser

Director of Medical Clinic I at University Hospital Carl Gustav Carus and at the National Center for Tumor Diseases Dresden, and Professor for Hematology/Oncology

Prof. Stephen Gilbert

Professor at Dresden University of Technology (Else Kröner Fresenius Center for Digital Health – EKFZ) with more than 15 years of experience in regulatory science and expertise in medical and IVD regulations

Dr. med. Katja Sockel

Senior Physician for Hematology/Oncology at Carl Gustav Carus University Hospital Dresden and Deputy Head of the Laboratory for Hematologic Cytology with clinical & research focus in myeloid neoplasia

Join our Revolution in Healthcare AI – Explore Careers at Cancilico!

Join Our Revolution in Healthcare image